| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1262-3636(07)70001-0 |
| P698 | PubMed publication ID | 12629442 |
| P2093 | author name string | Capron L | |
| P2860 | cites work | Hypertriglyceridemia as a cardiovascular risk factor | Q44268486 |
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Hormone replacement therapy | Q56995043 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| New evidence for beneficial effects of statins unrelated to lipid lowering | Q73366268 | ||
| Effects of estrogen replacement on the progression of coronary-artery atherosclerosis | Q74212886 | ||
| Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits | Q24655522 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| Dietary fat intake and prevention of cardiovascular disease: systematic review | Q28361678 | ||
| Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome | Q29029379 | ||
| Blood pressure, stroke, and coronary heart disease | Q29391703 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study | Q29617822 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
| Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses | Q33910496 | ||
| MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q33960122 | ||
| Case-control studies: research in reverse | Q34114044 | ||
| Hormone therapy and heart disease after the menopause | Q34417085 | ||
| Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease | Q36244821 | ||
| Risk factors for acute myocardial infarction in Indians: a case-control study | Q39425637 | ||
| Ischaemic heart disease: epidemiology, risk factors and cause | Q40292742 | ||
| A survey of 246 suggested coronary risk factors | Q40315800 | ||
| Cohort studies: marching towards outcomes | Q43474119 | ||
| Cardiovascular protection and blood pressure reduction: a meta-analysis | Q43782892 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 6-13 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Diabetes and Metabolism | Q15758385 |
| P1476 | title | What's in a risk factor? "He who strikes the ball". | |
| P478 | volume | 29 |
| Q73704506 | Current literature in diabetes |
| Q30239828 | Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function. |
| Q41430394 | Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. |
| Q27026813 | The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms |
Search more.